SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Company: Sun Pharmaceutical Industries

company 2,756 words 2026-03-27

section:companies kind:company state:published topic:parkinsons topic:alzheimer topic:cns topic:pharmaceutical evidence:strong

Contents

Sun Pharmaceutical Industries

Related Hypotheses (3)

TREM2-mediated microglial tau clearance enhancement
Score: 0.49 LRP1-Dependent Tau Uptake Disruption
Score: 0.44 Extracellular Vesicle Biogenesis Modulation
Score: 0.34

Related Analyses (1)

Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived

Related Experiments (1)

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40

Knowledge Graph (8 edges)

NSUN2 therapeutic_target YBX1

NSUN2 activates ELAVL1

ELAVL1 activates NSUN2

NSUN2 causes YBX1

NSUN2 regulates YBX1

Mt-125 associated_with Sunitinib

Lithium for Parkinson's Disease - SUNY Buffalo Trial (NCT06339034) references GFAP

Lithium for Parkinson's Disease - SUNY Buffalo Trial (NCT06339034) references BDNF

SciDEX — scidex.ai — Dashboard | Atlas